Gold Mining News – Lifestyle
Home
Sample Page
Author:
SK pharmteco Inc.
SK pharmteco Collaborates with Axle Informatics and the National Institutes of Health to Advance Rare Disease Gene Therapy Programs
May 7, 2026
SK pharmteco Achieves SBTi Validation for 2040 Net-Zero Science-Based Targets
May 5, 2026
SK pharmteco to Host Innovations in Pharmaceutical Manufacturing Symposium in Cambridge, Massachusetts
March 26, 2026
SK pharmteco and Prozomix Announce Strategic Collaboration to Enhance Biocatalysis Capabilities for Global Drug Manufacturing
March 24, 2026
SK pharmteco Reaffirms Three-Business-Unit Strategy, Strengthens Global Gene Therapy Business Unit with Funding Commitment
March 19, 2026
SK pharmteco Announces Successful FDA Inspection of Small Molecule Manufacturing Facility in La Porte, Texas
March 17, 2026
SK pharmteco Announces CGMP Qualification of its Commercial-Scale Viral Vector Manufacturing Facility in France
March 12, 2026